Cargando…
Cardio-oncology: management of cardiovascular toxicity
Traditional chemotherapeutic agents and newer targeted therapies for cancer have the potential to cause cardiovascular toxicities. These toxicities can result in arrhythmias, heart failure, vascular toxicity, and even death. It is important for oncologists and cardiologists to understand the basic d...
Autores principales: | Markman, Timothy M., Markman, Maurie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354320/ https://www.ncbi.nlm.nih.gov/pubmed/30755794 http://dx.doi.org/10.12688/f1000research.14542.1 |
Ejemplares similares
-
Cardio-Oncology: mechanisms of cardiovascular toxicity
por: Markman, Timothy M., et al.
Publicado: (2018) -
Intraperitoneal chemotherapy in the management of ovarian cancer: focus on carboplatin
por: Markman, Maurie
Publicado: (2009) -
Poly (ADP-ribose) polymerase inhibitors in the management of ovarian cancer
por: Markman, Maurie
Publicado: (2018) -
Pegylated liposomal doxorubicin: appraisal of its current role in the management of epithelial ovarian cancer
por: Markman, Maurie
Publicado: (2011) -
New developments in the anti-neoplastic drug management of ovarian cancer
por: Markman, Maurie
Publicado: (2013)